OST-tADC

N/A

Report date: 2024/08/23 11:05:05

Base Information

Drug NameOST-tADC
Drug Alias NameOST-tADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOS Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesOS Therapies Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A